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Summary
The enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase catalyzes the
conversion of HMG-CoA to mevalonate, a four-electron oxidoreduction that is the rate-limiting
step in the synthesis of cholesterol and other isoprenoids. The enzyme is found in eukaryotes and
prokaryotes; and phylogenetic analysis has revealed two classes of HMG-CoA reductase, the
Class I enzymes of eukaryotes and some archaea and the Class II enzymes of eubacteria and
certain other archaea. Three-dimensional structures of the catalytic domain of HMG-CoA
reductases from humans and from the bacterium Pseudomonas mevalonii, in conjunction with site-
directed mutagenesis studies, have revealed details of the mechanism of catalysis. The reaction
catalyzed by human HMG-CoA reductase is a target for anti-hypercholesterolemic drugs (statins),
which are intended to lower cholesterol levels in serum. Eukaryotic forms of the enzyme are
anchored to the endoplasmic reticulum, whereas the prokaryotic enzymes are soluble. Probably
because of its critical role in cellular cholesterol homeostasis, mammalian HMG-CoA reductase is
extensively regulated at the transcriptional, translational, and post-translational levels.
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Gene organization and evolutionary history 
The human hmgr gene that encodes the single human
HMG-CoA reductase is located on chromosome 5, map
location 5q13.3-5q14, and is over 24.8 kilobases (kb) long.
The 20 exons of the 4,475-nucleotide transcript, which range
in size from 27 to 1,813 base-pairs, encode the membrane-
anchor domain (exons 2-10), a flexible linker region (exons
10 and 11), and the catalytic domain (exons 11-20) of the
resulting 888-residue polypeptide (Figure 1). 
Genome sequencing has identified hmgr genes in organisms
from all three domains of life, and over 150 HMGR sequences
are recorded in public databases. Higher animals, archaea,
and eubacteria have only a single hmgr gene, although the
lobster has both a soluble and a membrane-associated
isozyme, both of which are encoded by a single gene). By
contrast, plants, which use both HMGR-dependent and
HMGR-independent pathways to synthesize isoprenoids,
have multiple HMGR isozymes that appear to have arisen by
gene duplication and subsequent sequence divergence [1].
Yeast has two HMGR isozymes derived from two different
genes (hmgr-1 and  hmgr-2). Comparison of amino-acid
sequences and phylogenetic analysis reveals two classes of
HMGR, the Class I enzymes of eukaryotes and some archaea
and the Class II enzymes of certain eubacteria and archaea,
suggesting evolutionary divergence between the two classes
(Figure 2, Table 1) [2,3]. The catalytic domain is highly con-
served in eukaryotes, but the membrane-anchor domain
(consisting of between two and eight membrane-spanning
helices) is poorly conserved, and the HMGRs of archaea and
of certain eubacteria lack a membrane-anchor domain.
Characteristic structural features 
The HMGRs of different organisms are multimers of a species-
specific number of identical monomers. High-resolutioncrystal structures have been solved for the Class I human
enzyme (HMGRH) [4,5] and for the Class II enzyme of
Pseudomonas mevalonii (HMGRP) [6,7], including protein
forms bound to either the HMG-CoA substrate or the
coenzyme  (NADH or NADPH) or both, or bound to statin
drugs, which are potent competitive inhibitors of HMGR
activity and thus lower cholesterol levels in the blood [8,9].
As reviewed in detail by Istvan [10], structural comparisons
reveal both similarities and significant differences between
the two classes of enzyme. The human HMGR has three
major domains (catalytic, linker and anchor), whereas the
P. mevalonii HMGR has only the catalytic domain (Figure 1).
Both HMGRH  and HMGRP have a dimeric active site with
residues contributed by each monomer, and a non-Rossmann-
type coenzyme-binding site (a three-dimensional structural
fold that contains a nucleotide-binding motif and is found in
many enzymes that use the dinucleotides NADH and NADPH
for catalysis). The core regions containing the catalytic domains
of the two enzymes have similar folds. Despite differences in
amino-acid sequence and overall architecture, functionally
similar residues participate in the binding of coenzyme A by the
two enzymes, and the position and orientation of four key
catalytic residues (glutamate, lysine, aspartate and histidine) is
conserved in both classes of HMGR.
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Figure 1
Schematic representation of the human hmgr gene and the human HMGRH and P. mevalonii HMGRP proteins. (a) The exon-intron structure of the
human hmgr gene, which extends from position 74717172 to position 74741998 of the human genome; positions refer to the Ensembl Transcript ID
for the human hmgr gene (ENST00000287936 [22]). The numbers indicate the start and end of each exon and intron and refer to the position in the
human genome sequence, omitting the first three digits (747); exons are indicated as filled boxes. Exon 1 is an untranslated region (UTR), as are the
last 1,758 nucleotides of exon 20. The exons encoding the membrane-anchor domain, a flexible linker region, and the catalytic domain are indicated
below the gene structure. (b) Human HMGR protein (HMGRH) is comprised of three domains: the membrane-anchor domain, a linker domain, and a
catalytic domain; within the catalytic domain subdomains have been defined. The N domain connects the L domain to the linker domain; the L domain
contains an HMG-CoA binding region; and the S domain functions to bind NADP(H). The cis-loop (indicated by an asterisk), a region present only in
HMGRH but not HMGRP, connects the HMG-CoA-binding region with the NADPH-binding region. (c) The HMGRP protein does not contain the
membrane-anchor domain or the linker domain but has a catalytic domain containing a large domain with an HMG-CoA binding region, and a small,
NAD(H)-binding domain. The active site of HMG-CoA reductase is present at the homodimer interface between one monomer that binds the
nicotinamide dinucleotide and a second monomer that binds HMG-CoA. The numbers underneath the diagrams in (b,c) denote amino acids (in the
single-letter amino-acid code) that are implicated in catalysis; S872 of HMGRH is reversibly phosphorylated. At the extreme carboxyl terminus of each
enzyme is a flap domain (approximately 50 amino acids in HMGRP and 25-30 amino acids in HMGRH) that closes over the active site during catalysis;
the flap domain is indicated by shading in (b,c). 
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K267 E83 D283 H381Unlike the central cores, the amino- and carboxy-terminal
regions of the catalytic domains show little similarity between
the human and P. mevalonii HMGR structures. The active site
of HMG-CoA reductase is at the interface of the homodimer
between one monomer that binds the nicotinamide dinu-
cleotide and a second monomer that binds the HMG-CoA. In
human HMGR, the catalytic lysine is found on the monomer
that binds the HMG-CoA and comes from the so-called
cis-loop (a section that connects the HMG-CoA-binding
region with the NADPH-binding region). In contrast, the
P. mevalonii HMGR lacks the cis-loop and the catalytic lysine
is contributed by the monomer that binds the nicotinamide
dinucleotide. HMGRP crystallizes as a trimer of dimers (which
are composed of identical subunits), but HMGRH crystallizes
as a tetramer (of identical units). HMGRP uses NADH as a
coenzyme, whereas HMGRH uses NADPH, but mutation to
alanine of the aspartyl residue of HMGRP that normally blocks
binding of NADPH can allow NADPH to serve - albeit poorly -
as the coenzyme for HMGRP. A 180o difference in the orienta-
tion of the nicotinamide ring of the coenzyme suggests that
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Figure 2
A phylogenetic tree of HMGRs. The tree includes 98 selected organisms that have hmgr genes; for plants, which have multiple isoforms, only isoform 1 of
each species is included in the tree. Roman numerals indicate the division of the family into two classes [2,3]. Phylogenetic analysis was performed using
aligned amino-acid sequences of HMGR catalytic domains; membrane anchor domains were excluded from analysis. Amino-acid sequence alignments
were generated using ClustalW [23] and the phylogenetic tree constructed with TreeTop [24] using the cluster algorithm with PHYLIP tree-type output.
Full species names and GenBank accession numbers of the sequences used are provided in Table 1. 
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Actinoplanes sp.
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S. pneumoniae
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L. lactis
E. faecium
L. plantarum
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S. haemolyticus
S. aureus
A. fulgidus
F. placidus
A. veneficus
A. lithotrophicus
P. mevalonii
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A. profundus
T. volcanium
T. acidophilum
P. torridus
B. bacteriovorus
L. johnsonii
B. burgdorferi
V. cholerae
S. grieolosporeus
Streptomyces sp.
P. abyssi
S. mansoni
Tomato
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Tobacco
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Wormwood
Rubber tree
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Class I
Class II
Muskmelon
Radish
A. thaliana
Cotton
P. blakesleeanus
Hamster
O. iheyensisthat the stereospecificity of the HMGRH hydrogen transfer is
opposite to that of HMGRP.
Comparisons between the HMGRP and HMGRH structures
reveal an overall similarity in how they bind statins, which
inhibit activity by blocking access of HMG-CoA to the active
site. There is a considerable difference in specific interac-
tions with inhibitor between the two enzymes, however
[8,9], accounting for the almost 104-fold higher Ki values for
inhibition of HMGRP by statin relative to the inhibition of
HMGRH (Ki is the equilibrium constant for an inhibitor
binding to an enzyme). There are significant differences in
the regions of the two proteins that bind statins. In both
enzymes the portion of the statin that resembles HMG (see
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Table 1 
Details of the sequences used for the phylogenetic tree in Figure 2
Organism name* Kingdom Accession
number
Mus musculus (mouse) Eukaryote XM_127496
Mesocricetus auratus (hamster) Eukaryote X00494
Rattus norvegicus (rat) Eukaryote BC064654
Homo sapiens (human) Eukaryote NM_000859
Gallus gallus (chicken) Eukaryote AB109635
Xenopus laevis (frog) Eukaryote M29258
Drosophila melanogaster (fruit fly) Eukaryote NM_206548
Homarus americanus (lobster) Eukaryote AY292877
Blatella germanica (cockroach) Eukaryote X70034
Dendroctonus jeffreyi (Jeffrey pine beetle) Eukaryote AF159136
Ips pini (bark beetle) Eukaryote AF304440
Ips paraconfusus (bark beetle) Eukaryote AF071750
Raphanus sativus (radish) Eukaryote X68651
Arabidopsis thaliana (thale-cress) Eukaryote NM_106299
Oryza sativa (rice) Eukaryote AF110382
Lycopersicon esculentum (tomato) Eukaryote AAL16927
Nicotinia tabacum (tobacco) Eukaryote AF004232
Cucumis melo (muskmelon) Eukaryote AB021862
Hevea brasiliensis (rubber tree) Eukaryote X54659
Pisum sativum (pea) Eukaryote AF303583
Solanum tuberosum (potato) Eukaryote L01400
Tagetes erecta (African marigold) Eukaryote AF034760
Catharanthus roseus (Madagascar periwinkle) Eukaryote M96068
Artemisia annua (wormwood) Eukaryote AF142473
Gossypium hirsutum (cotton) Eukaryote AF038046
Taxus x media (yew) Eukaryote AY277740
Andrographis paniculata (Indian herb) Eukaryote AY254389
Malus x domestica (apple) Eukaryote AY043490
Capsicum annuum (pepper) Eukaryote AF110383
Camptotheca acuminata Eukaryote U72145
Saccharomyces cerevisiae (baker’s yeast) Eukaryote M22002
Schizosaccharomyces pombe (fission yeast) Eukaryote CAB57937
Candida utilis  Eukaryote AB012603
Trypanosoma cruzi (trypanosome) Eukaryote L78791
Schistosoma mansoni Eukaryote M27294
Leishmania major (trypanosome) Eukaryote AF155593
Dictyostelium discoideum Eukaryote L19349
Caenorhabditis elegans Eukaryote NM_066225
Strongylocentrotus purpuratus (sea urchin) Eukaryote NM_214559
Dicentrarchus labrax (European sea bass) Eukaryote AY424801
Penicillium citrinum  Eukaryote AB072893
Ustilago maydis  Eukaryote XM_400629
Eremothecium gossypii  Eukaryote NM_210364
Gibberella zeae  Eukaryote XM_389373
Gibberella fujikuroi  Eukaryote X94307
Sphaceloma manihoticola  Eukaryote X94308
Aspergillus nidulans  Eukaryote EAA60025
Neurospora crassa  Eukaryote XM_324891
Phycomyces blakesleeanus  Eukaryote X58371
Archaeoglobus fulgidus Archaea NC_000917
Sulfolobus solfataricus Archaea U95360
Oceanobacillus iheyensis Archaea NC_004193
Thermoplasma volcanium Archaea BAB60335
Halobacterium sp Archaea AAG20075
Methanosarcina mazei Archaea AAM30031
Haloarcula hispanica Archaea AF123438
Thermoplasma acidophilum Archaea CAC11548
Picrophilus torridus Archaea AE017261
Archaeoglobus veneficus Archaea AJ299204
Table 1 (continued)
Organism name Kingdom Accession
number
Ferroglobus placidus Archaea AJ299206
Archaeoglobus profundus Archaea AJ299205
Archaeoglobus lithotrophicus Archaea AJ299203
Haloferax volcanii Archaea M83531
Pyrococcus furiosus Archaea AAL81972
Pyrococcus abyssi Archaea AJ248284
Methanococcus maripaludis Archaea CAF29643
Methanocaldococcus jannaschii Archaea AAB98699
Methanosarcina acetivorans Archaea AAM06446.
Methanopyrus kandleri Archaea AAM01570
Sulfolobus tokodaii Archaea AP000986
Aeropyrum pernix Archaea AP000062
Methanothermobacter thermautotrophicus Archaea AAB85068
Pyrobaculum aerophilum Archaea AAL64009
Bdellovibrio bacteriovorus Eubacteria BX842650
Lactobacillus plantarum Eubacteria AL935253
Streptococcus agalactiae Eubacteria CAD47046
Lactococcus lactis Eubacteria AE006387
Vibrio cholerae Eubacteria AAF96622
Vibrio vulnificus Eubacteria AAO07090.
Vibrio parahaemolyticus Eubacteria BAC62311
Enterococcus faecalis Eubacteria AAO81155
Lactobacillus johnsonii Eubacteria AE017204
Chloroflexus aurantiacus Eubacteria AJ299212
Enterococcus faecium Eubacteria AF290094
Listeria monocytogenes Eubacteria AE017324
Listeria innocua Eubacteria CAC96053
Streptococcus pneumoniae Eubacteria AF290098
Staphylococcus epidermidis Eubacteria AF290090
Staphylococcus haemolyticus Eubacteria AF290088
Staphylococcus aureus Eubacteria AF290086
Streptomyces griseolosporeus Eubacteria AB037907
Streptomyces sp. Eubacteria AB015627
Streptococcus pyogenes Eubacteria AF290096
Streptococcus mutans Eubacteria AAN58647
Paracoccus zeaxanthinifaciens Eubacteria AJ431696
Pseudomonas mevalonii Eubacteria M24015
Borrelia burgdorferi Eubacteria AE001169.
Actinoplanes sp. Eubacteria AB113568
*Common names are indicated in parentheses Accession numbers for
each sequence are available from sequence databases accessible through
the National Center for Biotechnology Information [25]. Figure 3) occupies the HMG portion of the HMG-CoA-
binding pocket, and the non-polar region partially occupies a
portion of the coenzyme-A-binding site. For HMGRP, this
impairs closure over the active site of the ‘tail’ domain that
contains the catalytic histidine.
Localization and function
HMGRs of eukaryotes are localized to the endoplasmic
reticulum (ER), and are directed there by a short portion of
the amino-terminal domain (prokaryotic HMGRs are soluble
and cytoplasmic). In humans, the reaction catalyzed by
HMGR is the rate-limiting step in the synthesis of cholesterol,
which maintains membrane fluidity and serves as a precursor
for steroid hormones. In plants, a cytosolic HMG-CoA
reductase participates in the synthesis of sterols, which are
involved in plant development, certain sesquiterpenes, which
are important in plant defense mechanisms against herbivores,
and ubiquinone, which is critical for cellular protein turnover.
In plastids, however, these compounds are synthesized via
a pathway that does not involve mevalonate or HMGR [1].
Various plant HMGR isozymes function in fruit ripening and
in the response to environmental challenges such as attack by
pathogens. In yeast, either of the two ER-anchored HMGR
isozymes can provide the mevalonate needed for growth.
Enzyme mechanism
The reaction catalyzed by HMGR is:
(S)-HMG-CoA + 2 NADPH + 2 H+  (R)-mevalonate + 2
NADP+ + CoA-SH.
with the (S)-HMG-CoA and (R)-mevalonate designations
referring to the stereochemistry of the substrate and
product  (enzymatic reactions are stereospecific and the
(R)-HMG-CoA isomer is not a substrate for HMGR). This
three-stage reaction involves two reductive stages and the
formation of enzyme-bound mevaldyl-CoA and mevaldehyde
as probable intermediates:
Stage 1: HMG-CoA + NADPH + H+[Mevaldyl-CoA] + NADP+
Stage 2: [Mevaldyl-CoA]  [Mevaldehyde] + CoA-SH
Stage 3: [Mevaldehyde] + NADPH + H+Mevalonate + NADP+
Kinetic analysis of point mutants of HMGRP and of HMGRH,
and inspection of the crystal structures of HMGRP and
HMGRH, has identified an aspartate, a glutamate, a histidine,
and a lysine that are likely to be important and have suggested
their probable roles in catalysis (Figure 4) [11]. 
Regulation 
A highly regulated enzyme, HMGRH is subject to transcrip-
tional, translational, and post-translational control [12] that
can result in changes of over 200-fold in intracellular
levels of the enzyme. The transcription factor sterol regulatory
element-binding protein 2 (SREBP-2) participates in reg-
ulating levels of HMGRH mRNA in response to the level of
sterols [13]; the regulatory process is as follows. At the ER
membrane or the nuclear envelope, SREBP-2 binds to
SREBP cleavage activating protein (SCAP) to form a
SCAP-SREBP complex that functions as a sterol sensor. The
proteins Insig-1 and Insig-2 bind to SCAP when cellular
cholesterol levels are high and prevent movement of the
SCAP-SREBP complex from the ER to the Golgi. In cells
depleted of cholesterol, Insig-1 and Insig-2 allow activation
of the SCAP-SREBP complex and its translocation to the
Golgi, where SREBP is cleaved at two sites. Cleavage releases
the amino-terminal basic helix-loop-helix (bHLH)
domain, which enters the nucleus, where it functions as a
transcription factor that recognizes non-palindromic
decanucleotide sequences of DNA called sterol-regulatory
elements (SREs). Binding of the bHLH domain of SREBP to
an SRE promotes transcription of the hmgr gene.
Degradation of HMGRH involves its transmembrane regions
[14]: removal of two or more transmembrane regions abolishes
the acceleration of HMGRH degradation that occurs under
certain conditions [12,15]: degradation is induced by a
non-sterol, mevalonate-derived metabolite alone or by a
sterol plus a mevalonate-derived non-sterol metabolite,
possibly farnesyl pyrophosphate or farnesol. Four con-
served phenylalanines in the sixth membrane span of the
transmembrane region are essential for degradation of
HMGRH [16]. Insig-1 also functions in the degradation of
HMGRH [17]: when cholesterol levels are high, SCAP and
HMGRH compete for binding to Insig-1. If SCAP binds Insig-1,
the SCAP-Insig-1 complex is retained in the Golgi, whereas if
HMGRH binds Insig-1, HMGRH is ubiquinated on lysine 248
and is rapidly degraded through a ubiquitin-proteasome
mechanism [18].
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Figure 3
Structures of lovastatin, a statin drug that competitively inhibits HMGR,
and of HMG-CoA. It can be seen that the portion of the drug shown here
at the top resembles the HMG portion of HMG-CoA. 
COOH
O
HO HO
OH
O H
H
H
COOH
O
SCoA
Lovastatin
HMG-CoAThe catalytic activity of the HMGRs of higher eukaryotes is
attenuated by phosphorylation of a single serine, which in
the case of HMGRH is at position 872 [19]. The location of
this serine - six residues from the catalytic histidine, a
spacing conserved in all higher eukaryote HMGRs - sug-
gests that the phosphoserine may interfere with the ability
of this histidine to protonate the inhibitory CoAS- thioanion
that is released in stage 2 of the reaction mechanism. Alter-
natively, it may interfere with closure of the flap domain, a
carboxy-terminal region that is thought to close over the
active site to facilitate catalysis, a step thought to be
essential for formation of the active site [7]. Subsequent
dephosphorylation restores full catalytic activity. HMGR
kinase (also called AMP kinase) phosphorylates HMGR; the
primary phosphatase in vivo is thought to be protein
phosphatase 2A (PP2A), but both phosphatases 2A and 2B
can catalyze dephosphorylation of vertebrate HMGR in
vitro [20]. HMGRH activity therefore responds to hormonal
control through AMP levels and PP2A activity. Phosphory-
lation of serine 577 of A. thaliana HMGR isozyme 1 by a
plant HMGR kinase that does not require 5’-AMP attenuates
activity, and restoration of HMGR activity follows from
dephosphorylation [21]. As many plant genes encode a
putative target serine surrounded by an apparent AMP
kinase recognition motif, it is probable that most plant
HMGRs are regulated by phosphorylation. Yeast HMGR
activity is, however, unaffected by AMP kinase. The phos-
phorylation state of HMGR does not affect the rate at
which the protein is degraded. 
Frontiers
Several basic unresolved questions concern how phosphory-
lation controls the catalytic activity of HMGRs; solution of
the structures of phosphorylated HMGRs should reveal
more of the precise mechanism. The protein kinases, phos-
phatases, and signal-transduction pathways that participate in
short-term regulation of HMGR activity are yet to be
elucidated. Finally, the physiological roles served by the
multiple ways in which HMGR is regulated require clarifi-
cation. On the medical side, continuing intense competition
between drug companies for a share of the lucrative worldwide
market for hypercholesterolemic agents should result in new
statin drugs with modified pharmacodynamic and metabolic
properties that not only lower plasma cholesterol levels
more effectively but more importantly minimize undesirable
side effects.
References
1. Laule O, Furholz A, Chang HS, Zhu T, Wang X, Heifetz PB,
Gruissem W, Lange M: Crosstalk between cytosolic and plas-
tidial pathways of isoprenoid biosynthesis in Arabidopsis
thaliana. Proc Natl Acad Sci USA 2003, 100:6866-6871.
A study of the regulation of both mevalonate and mevalonate indepen-
dent pathways for isoprenoid synthesis in plants.
2. Bochar DA, Stauffacher CV, Rodwell VW: Sequence comparisons
reveal two classes of 3-hydroxy-3-methylglutaryl coenzyme
A reductase. Mol Genet Metab 1999, 66:122-127.
This article reported the classification of HMG-CoA reductases into
Class I and Class II enzymes on the basis of sequence comparison. The
authors utilized phylogenetic analysis to analyze a plethora of genomic
sequences of various organisms.
3. Hedl M, Tabernero L, Stauffacher CV, Rodwell VW: Class II 3-hydroxy-3-
methylglutaryl coenzyme A reductases. J Bacteriol 2004, 186:1927-1932.
248.6 Genome Biology 2004, Volume 5, Issue 11, Article 248 Friesen and Rodwell http://genomebiology.com/2004/5/11/248
Genome Biology 2004, 5:248
Figure 4
Proposed reaction mechanism for HMGRP [7,18]. The side groups of the key catalytic residues, Lys267, Asp283, Glu83, and His381, are shown, and the
substrate and products are shown with R representing the HMG portion. The reaction follows three stages (see text for details). A basically similar
mechanism has been proposed for HMGRH [4].
Asp283 Asp283 Asp283 Asp283
Glu83 Glu83 Glu83 Glu83
Lys267 Lys267 Lys267 Lys267
His381 His381 His381
CoA-S CoA-S NADH NAD+ NADH
CoA-SH
NAD+
H
H
H
H
H
C C
C
C
O
O O O
O O
O
O
CC
C
O
C
CC
C
O
O
O
C
O
O
O O
O
H
H
H H
H
R
R
R
R
N N N
N
O O
H
N
H
H
H
O
H
H
H
H
H
H
N N
N N H N
−
−
−
− −
−
−
−
+
+ + +
+ +
HMG-CoA Mevaldyl-CoA Mevaldehyde Mevalonate
..
..
1
2
3A review article detailing current research and thought concerning
Class II forms of the enzyme, including the HMGRs of many pathogenic
bacteria.
4. Istvan ES, Palnitkar M, Buchanan SK, Deisenhofer J: Crystal struc-
ture of the catalytic portion of human HMG-CoA reductase:
insights into regulation of activity and catalysis. EMBO J 2000,
19:819-830.
This article and [5] reported the crystal structure of the human HMG-
CoA reductase catalytic domain, providing numerous insights into catal-
ysis by a Class I HMG-CoA reductase. 
5. Istvan ES, Deisenhofer J: The structure of the catalytic portion
of human HMG-CoA reductase. Biochim Biophys Acta
2000,1529:9-18.
See [4]. 
6. Lawrence CM, Rodwell VW, Stauffacher CV: The crystal struc-
ture of Pseudomonas mevalonii HMG-CoA reductase at 3.0 Å
resolution. Science 1995, 268:1758-1762.
This article reports the first HMG-CoA reductase structure that was
solved.
7. Tabernero LD, Bochar DA, Rodwell VW, Stauffacher CV: Substrate-
induced closure of the flap domain in the ternary complex
structures provides new insights into the mechanism of
catalysis by 3-hydroxy-3-methylglutaryl-CoA reductase. Proc
Natl Acad Sci USA 1999, 96:7167-7171.
The original structure of P. mevalonii HMG-CoA reductase [6] lacked a
portion of the enzyme known to be critical for catalysis. This article
provided insight into the catalytic mechanism by solving the structure of
the original missing region.
8. Istvan ES, Deisenhofer J: Structural mechanism for statin inhi-
bition of HMG-CoA reductase. Science 2001, 292:1160-1164.
This article reports a structural explanation for inhibition of human
HMG-CoA reductase by statins, which are widely prescribed drugs for
hypercholesterolemia.
9. Tabernero L, Rodwell VW, Stauffacher CV: Crystal structure of a
statin bound to a class II hydroxymethylglutaryl-CoA
reductase. J Biol Chem 2003, 278:19933-19938.
The authors detail the interaction of P. mevalonii HMG-CoA reductase,
a Class II enzyme, with statins.
10. Istvan ES: Bacterial and mammalian HMG-CoA reductases:
related enzymes with distinct architectures. Curr Opin Struct
Biol 2001, 11:746-751.
A review that provides insight into the relationships between Class I and
Class II HMG-CoA reductases, both in terms of structure and evolution.
11. Bochar DA, Friesen JA, Stauffacher CV, Rodwell VW: Biosynthesis
of mevalonic acid from acetyl-CoA. In  Isoprenoids Including
Carotenoids and Steroids. Edited by Cane D. New York: Pergamon
Press, 1999, 15-44.
A comprehensive review article detailing the catalysis, structure, and
regulation of HMG-CoA reductase. It is written from the point of view
of natural products synthesis.
12. Goldstein JL, Brown MS: Regulation of the mevalonate
pathway. Nature 1990, 343:425-430.
The first major report on the regulation of HMG-CoA reductase.
13. Horton JD, Goldstein JL, Brown MS: SREBPs: activators of the
complete program of cholesterol and fatty acid synthesis in
the liver. J Clin Invest 2002, 109:1125-1131.
A recent review detailing the role of sterol regulatory element binding
proteins (SREBPs) in the regulation of cholesterol biosynthesis. This is
the transcriptional control for HMG-CoA reductase. 
14. Mitropoulos KA, Venkatesan S: Membrane-mediated control of
HMG-CoA reductase activity. In Regulation of HMG-CoA Reduc-
tase. Edited by Preiss B. Orlando: Academic Press, 1985, 1-48.
A classical review article summarizing the role of the membrane anchor
domain in HMG-CoA reductase degradation.
15. Jingami H, Brown MS, Goldstein JL, Anderson RJ, Luskey KL: Partial
deletion of membrane-bound domain of 3-hydroxy-3-
methylglutaryl coenzyme A reductase eliminates sterol-
enhanced degradation and prevents formation of crystalloid
endoplasmic reticulum. J Cell Biol 1987, 104:1693-1704.
The original report of the sterol-mediated regulation of HMG-CoA
reductase degradation and localization of the region responsible for
mediating this degradation.
16. Xu L, Simoni RD: The inhibition of degradation of 3-hydroxy-
3-methylglutaryl coenzyme A (HMG-CoA) reductase by
sterol regulatory element binding protein cleavage-activating
protein requires four phenylalanine residues in span 6 of
HMG-CoA reductase transmembrane domain. Arch Biochem
Biophys 2003, 414:232-243. 
A study of the structure-function relationships between HMG-CoA
reductase degradation and the sterol cleavage activating protein
(SCAP).
17. Sever N, Yang T, Brown MS, Goldstein JL, DeBose-Boyd RA: Accel-
erated degradation of HMG-CoA reductase mediated by
binding of insig-1 to its sterol-sensing domain. Mol Cell 2003,
11:25-33.
The authors identified the role of the protein insig-1 in regulation of
HMG-CoA reductase by degradation.
18. Sever N, Song BL, Yabe D, Goldstein JL, Brown MS, DeBose-Boyd
RA: Insig-dependent ubiquitination and degradation of mam-
malian 3-hydroxy-3-methylglutaryl-CoA reductase stimu-
lated by sterols and geranylgeraniol. J Biol Chem 2003,
278:52479-52490.
This study described the relationship between ubiquitination, degrada-
tion, and the protein insig-1 in HMG-CoA reductase degradation.
19. Sato R, Goldstein JL, Brown MS: Replacement of serine-871 of
hamster 3-hydroxy-3-methylglutaryl-CoA reductase pre-
vents phosphorylation by AMP-activated kinase and blocks
inhibition of sterol synthesis induced by ATP depletion. Proc
Natl Acad Sci USA 1993, 90:9261-9265.
In this study, the authors identified the specific amino acid of mam-
malian HMG-CoA reductase that is phosphorylated and mediates regu-
lation of HMG-CoA reductase by reversible phosphorylation.
20. Hardie, DG: The AMP-activated protein kinase cascade: the
key sensor of cellular energy status. Endocrinology 2003,
144:5179-5183.
A review article describing the AMP-activated protein kinase (AMPK)
that phosphorylates HMG-CoA reductase.
21. Dale S, Arro M, Becerra B, Morrice NG, Boronat A, Hardie DG,
Ferrer A: Bacterial expression of the catalytic domain of 3-
hydroxy-3-methylglutaryl-CoA reductase (isoform hmgr1)
from Arabidopsis thaliana, and its inactivation by phosphory-
lation at Ser577 by Brassica oleracea 3-hydroxy-3-methyl-
glutaryl-CoA reductase kinase. Eur J Biochem 1995,
233:506-513.
A study that illustrated that plant HMG-CoA reductases are probably
regulated by reversible phosphorylation.
22. Ensembl Human Genome browser
[http://www.ensembl.org/Homo_sapiens/]
Ensembl information about the human HMG-CoA reductase gene and
transcript details.
23. Higgins D, Thompson J, Gibson T, Thompson JD, Higgins DG,
Gibson TJ: CLUSTAL W: Improving the sensitivity of pro-
gressive multiple sequence alignment through sequence
weighting, position-specific gap penalties and weight matrix
choice. Nucleic Acids Res 1994, 22:4673-4680.
An article describing the CLUSTAL W program, which is used for mul-
tiple sequence alignments of amino-acid sequences.
24. TreeTop - Phylogenetic tree prediction
[http://www.genebee.msu.su/services/phtree_reduced.html] 
A program for phylogenetic tree generation.
25. National Center for Biotechnology Information
[http://www.ncbi.nlm.nih.gov] 
The NCBI contains a vast amount of sequence information, including
protein and nucleic acid sequences for HMG-CoA reductases and
information on the sequencing of genomes of organisms containing
HMG-CoA reductase isoforms. 
c
o
m
m
e
n
t
r
e
v
i
e
w
s
r
e
p
o
r
t
s
d
e
p
o
s
i
t
e
d
 
r
e
s
e
a
r
c
h
i
n
t
e
r
a
c
t
i
o
n
s
i
n
f
o
r
m
a
t
i
o
n
r
e
f
e
r
e
e
d
 
r
e
s
e
a
r
c
h
http://genomebiology.com/2004/5/11/248                                         Genome Biology 2004, Volume 5, Issue 11, Article 248 Friesen and Rodwell  248.7
Genome Biology 2004, 5:248